Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Maddy Herzfeld, discusses the challenges practices are facing when implementing patient engagement

Maddy Herzfeld, R.N., B.S.N., O.C.N., Chief Executive Officer, Carevive Systems, discusses the challenges practices are facing when implementing patient engagement

Published: 13 February 2017

Recent Videos: Cancer Center Business Summit

video

Charles Saunders, MD, on the operational changes necessary to succeed in a value-based environment

Dr. Saunders, Chief Executive Officer, Integra Connect, explains the kind of operational transformation that will be required of oncologists to ...

video

Charles Saunders, MD, discusses how value-based care is driving technology innovation in oncology

Dr. Saunders, Chief Executive Officer, Integra Connect, explains how the movement towards value-based care is driving technology innovation in oncology.

video

Charles Saunders, MD, considers EHR providers in an era of value-based care

Dr. Saunders, Chief Executive Officer, Integra Connect, offers his opinion on what EHR providers have missed in terms of supporting ...

video

Marcus Neubauer, MD, discusses if clinical pathways create value in cancer care

Marcus Neubauer, MD, VP & Medical Director, McKesson Specialty Health, discusses if clinical pathways create value in cancer care

video

Jonathan Hirsch, on precision medicine software helping oncologists make therapeutic decisions

Jonathan Hirsch, President and Founder, Syapse, on precision medicine software helping oncologists make therapeutic decisions at the point of care

video

Maddy Herzfeld, on how oncology practices consume patient-reported data to improve patient care

Maddy Herzfeld, R.N., B.S.N., O.C.N., Chief Executive Officer, Carevive Systems, on how oncology practices consume patient-reported data to improve patient ...

video

Mike Kolodziej, MD, on how the clinical data set at Flatiron helps oncologists

Mike Kolodziej, MD, National Medical Director, Managed Care Strategy, Flatiron Health, discusses how the clinical data set at Flatiron helps ...

video

Mike Kolodziej, MD, discusses how technology is helping reform the way practices operate

Mike Kolodziej, MD, National Medical Director, Managed Care Strategy, Flatiron Health, discusses how technology is helping reform the way community ...

video

Mike Kolodziej, MD, explains how Flatiron analytics help practices succeed in value based care

Mike Kolodziej, MD, National Medical Director, Managed Care Strategy, Flatiron Health, explains how Flatiron analytics help practices succeed in value ...

video

Maddy Herzfeld, discusses the challenges practices are facing when implementing patient engagement

Maddy Herzfeld, R.N., B.S.N., O.C.N., Chief Executive Officer, Carevive Systems, discusses the challenges practices are facing when implementing patient engagement

Related Videos

video-image

Patricia Goldsmith shares what CancerCare is doing to help patients with financial toxicity

video-image

Nicholas J. Vogelzang, MD, FASCO, FACP, speculates on the cost implications of abiraterone

video-image

Randall Oyer, MD, describes how ACCC is supporting practices that are participating in OCM

video-image

Randall Oyer, MD, reveals the challenges and solutions his practice is finding as a result of OCM

video-image

Randall Oyer, MD, shares major themes emerging from the OCM

video-image

Randall Oyer, MD, on how OCM is helping the healthcare system transition from volume to value

video-image

Leonard Saltz, MD, elaborates on what interventions could help alleviate financial toxicity

video-image

Leonard Saltz, MD, on how to begin the conversation with patients about financial toxicity

video-image

Andrew Pecora, MD, FACP, CPE, on the implications of healthcare and reimbursement reform

video-image

Andrew Pecora, MD, FACP, CPE, describes the movement to value-based reimbursement

video-image

Andrew Pecora, MD, FACP, CPE, on healthcare reform and the move from volume to value in oncology

video-image

Debra Patt, MD, MPH, MBA, speculates on upcoming changes in the 340B program

video-image

Lucio Gordan, MD, shares his concerns with PBMs as they affect community oncology practices

video-image

David Eagle, MD, shares how his small practice is successful in today’s oncology environment

video-image

David Eagle, MD, compares the rate of oncology spending to rate of total healthcare spending

video-image

David Eagle, MD, evaluates what part of total oncology care spending is drug spending

video-image

Joseph Lynch, MD, on why independent community oncology practices join hospital systems

video-image

Skip Burris, MD, shares how clinical pathways impact prescribing decisions

video-image

Skip Burris, MD, on the impact of OCM on large community practices

video-image

Bruce Feinberg, DO, on what community oncologists should consider with MACRA, MIP’s and OCM

video-image

Jeff Patton, MD, shares how clinical pathways help with value-based efforts

video-image

Jeff Patton, MD, on whether the Oncology Care Model impacts the prescribing of oral cancer agents

video-image

Jeff Patton, MD, explains how Tennessee Oncology has transformed to participate in OCM

video-image

Lucio Gordan, MD, considers how 340B is impacting physicians and practices

video-image

Robert Baird Jr. reflects on how his practice has changed as a result of OCM

video-image

Edward Li on how clinical pathways are making progress towards their original goals

video-image

Edward Li reflects on how pathways have impacted oncology treatment over the last 5 years

video-image

Ted Okon lists key takeaways from the 2017 COA meeting

video-image

Ted Okon describes how PBMs affect oncologists and cancer patients

video-image

Ted Okon shares the latest news on the 340B policy

video-image

Ben Jones gives advice to practices interested in advocating for community oncology

video-image

Lalan Wilfong, MD, shares lessons from his experience participating in OCM

video-image

Lalan Wilfong, MD, explains how OCM has impacted cancer patients in his practice

video-image

Lalan Wilfong, MD, provides opinion on how OCM is changing his practice

video-image

Debra Patt, MD, considers how community oncology contributes to clinical research advancement

video-image

Debra Patt, MD, on technological advances in cancer care and community oncology

video-image

Debra Patt, MD, shares how community oncology has contributed to advances in population health

video-image

Debra Patt, MD, elaborates on how community oncology contributes to the Cancer Moonshot

video-image

Jeff Vacirca, MD, shares how COA is addressing the DIR fees coming from PBMs

video-image

Jeff Vacirca, MD, on COA’s efforts to represent community oncologists

video-image

Jeff Vacirca, MD, discusses DIR fees and how COA hopes to solve the PBM fee problem

video-image

Jeff Vacirca, MD, on how COA is addressing Part B concerns among community oncologists

video-image

Lucio Gordan, MD, on how community oncology practices can utilize their own data

video-image

Lucio Gordan, MD, reflects on how he sees community oncology using big data

video-image

Matt Farber provides insight on the evolution of specialty pharmacies

video-image

Matt Farber explains the role of specialty pharmacy in delivering quality cancer care

video-image

David Eagle, MD, compares small, community oncology practices with large practices and hospitals

video-image

Ray Bailey on how participation in OCM impacts the in-house pharmacy at FCS

video-image

Patrick Cobb, MD, on cancer care costs in hospital outpatient and community settings

video-image

Brad Prechtl offers his opinion on how size influences community oncology practices

video-image

William Harwin, MD, on how clinical pathways impact treatment decisions at FCS

video-image

William Harwin, MD, explains how he manages the quality measures required for OCM

video-image

William Harwin, MD, on working with local payers to deliver quality care

video-image

William Harwin, MD, talks changes at Florida Cancer Specialists since participating in OCM

video-image

Barbara McAneny, MD, discusses 1 sided and 2 sided risk associated with participation in the OCM

video-image

Barbara McAneny, MD, shares her concerns with the way OCM is progressing at this point

video-image

Ricky Newton tells us how COA is addressing the PBM DIR fees and helping community oncology

video-image

Bobby Green, MD, on how oncologists can leverage data to understand real quality care

video-image

Barbara McAneny, MD, explains how the AMA and community oncology should interact

video-image

Ana Aparicio, MD, on immunotherapy as a future treatment guideline for metastatic prostate cancer

video-image

Nicholas J. Vogelzang, MD, FASCO, FACP, on immunotherapy and metastatic prostate cancer

video-image

Nicholas J. Vogelzang, MD, FASCO, FACP, on BRCA1 and BRCA2 genetic testing as guidelines

video-image

Charles Saunders, MD, on the operational changes necessary to succeed in a value-based environment

video-image

Charles Saunders, MD, considers EHR providers in an era of value-based care

video-image

Charles Saunders, MD, discusses how value-based care is driving technology innovation in oncology

video-image

Neal D. Shore, MD, FACS, on BRCA1 and BRCA2 genetic testing as guidelines for prostate cancer

video-image

Maddy Herzfeld, discusses the challenges practices are facing when implementing patient engagement

video-image

Maddy Herzfeld, on solutions available for practices to implement better patient engagement

video-image

Maddy Herzfeld, on how oncology practices consume patient-reported data to improve patient care

video-image

Marcus Neubauer, MD, explains how clinical pathways save money when treating cancer

video-image

Marcus Neubauer, MD, discusses if clinical pathways create value in cancer care

video-image

Marcus Neubauer, MD, explains how clinical pathways differ from clinical guidelines

video-image

Marcus Neubauer, MD, discusses how practices and administrators can build higher pathway compliance

video-image

Mike Kolodziej, MD, explains the impact of the ACA on the insurance industry

video-image

Mike Kolodziej, MD, talks about how CMMI is changing the health care system

video-image

Mike Kolodziej, MD, discusses how technology is helping reform the way practices operate

video-image

Mike Kolodziej, MD, on how the clinical data set at Flatiron helps oncologists

video-image

Mike Kolodziej, MD, explains how Flatiron analytics help practices succeed in value based care

video-image

Jonathan Hirsch, President and Founder, Syapse, on the value of sharing patient-specific information

video-image

Jonathan Hirsch, discusses how precision medicine is being used to help improve cancer treatment

video-image

Jonathan Hirsch, on precision medicine software helping oncologists make therapeutic decisions

video-image

Ira Klein, MD, on what the shift toward oral oncolytics means for the supply chain

video-image

Ed Bassin, Ph.D., on what oncologists should be thinking about as they approach value based care

video-image

Ed Bassin, Ph.D., on working with hospital-based cancer centers vs community practices

video-image

Ed Bassin, Ph.D., on if there will be health care savings with the implementation of the OCM

video-image

Ed Bassin, Ph.D., explains the challenges for oncologists and practices with the OCM model

video-image

Ira Klein, MD, explains how risk management changes the way we manage supply chain

video-image

Ira Klein, MD, discusses how limited distribution impacts the delivery of oral cancer agents

video-image

Diana Verrilli, McKesson Specialty Health, on how claims data is being used

video-image

Diana Verrilli, McKesson Specialty Health, on how claims data can be used in the OCM model

video-image

Steve D’Amato, R.Ph., talks about data capture and data analytics at New England Cancer Specialists

video-image

Steve D’Amato, R.Ph., talks about what technology his practice adopted to participate in OCM

video-image

Steve D’Amato, R.Ph., on why this is a challenging time for oncology practices

video-image

Steve D’Amato, R.Ph., explains how his practice helps patients get access to cancer care

video-image

Steve D’Amato, R.Ph., on whether the ACA changed access to care at New England Cancer Specialists

video-image

Jeffrey Scott, MD, shares the highest-impact areas of focus for value-based care savings

video-image

Jeffrey Scott, MD, on how important the drug channel is compared to reduction in hospitalizations

video-image

Jeffrey Scott, MD, discusses best practices for a GPO to help with value-based savings

video-image

Jeffrey Scott, MD, explains his vision for how GPOs must evolve in the era of value-based care

video-image

Bobby Green, MD, on using genomic data to prescreen eligibility for clinical trials

video-image

Bobby Green, MD, discusses collaboration efforts between Flatiron and Foundation Medicine

video-image

Bobby Green, MD, on leveraging genomic testing into actionable data

video-image

Dave Terry, Chief Executive Officer, on the keys to success when participating in APMs

video-image

Dave Terry, Chief Executive Officer, shares his thoughts on Alternative Payment Models of the future

video-image

Dave Terry, Chief Executive Officer, explains why practices should participate in APMs

video-image

James Hamrick, MD, shares his thoughts on how we are evolving toward a learning health care system

video-image

Debra Patt, MD, on what tele-health brings to cancer care

video-image

Debra Patt, MD, explains how data systems help with patient care delivery in community oncology

video-image

Linda Bosserman, MD, explains what MACRA means for oncologists today

video-image

Linda Bosserman, MD, discusses the highlights of the MACRA panel at CCBS 2017

video-image

Lili Brillstein, M.P.H., explains the primary goal of an episode of care

video-image

Lili Brillstein, M.P.H., explains how an episode of care is different from a bundled payment

video-image

Harlan Levine, MD, tells us about the continuous cycle of learning and improving at City of Hope

video-image

Harlan Levine, MD, on the philosophy for establishing quality metrics as they relate to an ACO

video-image

James Hamrick, MD, on using real world evidence to learn how to treat cancer patients

video-image

Lili Brillstein, M.P.H., shares her thoughts on the keys to success to make episodes of care work

video-image

Lili Brillstein, M.P.H., explains the requirements that must be met in an episode assessment

video-image

Harlan Levine, MD, on treating patients in this era of high cost cancer drugs

video-image

Harlan Levine, MD, on how cancer care navigators impact quality of care at City of Hope

video-image

James Hamrick, MD, explains how EMRs help connect patients and caregivers

video-image

Debra Patt, MD, explains how decision support tools improve the quality and delivery of cancer care

video-image

Debra Patt, MD, explains using predictive analytics to improve cancer care delivery

video-image

Linda Bosserman, MD, explains “Pick Your Pace” as it relates to participation in MACRA

video-image

Linda Bosserman, MD, on deciding whether to participate in MIPS or AAPM

video-image

Alan P. Venook, MD, explains how the 80405 study and its impact on treatment guidelines

video-image

Chadi Nabhan, MD, on payers using clinical pathways in hematological malignancies vs solid tumors

video-image

Chadi Nabhan, MD, on incorporating clinical pathways into CLL and other hematologic malignancies

video-image

Charles Bane, MD, touches on the COME HOME project while discussing the Oncology Care Model

video-image

Charles Bane, MD, touches on the COME HOME project while discussing the Oncology Care Model

video-image

Charles Bane, MD, discusses the practicality of the value tool at Dayton Physicians Network

video-image

Perspective on the NCCN Evidence Blocks by Charles Bane, MD

video-image

Perspective on the ASCO Value Framework by Charles Bane, MD

video-image

Bruce Gould, MD, explains how the value tools could be used in the community practice setting

video-image

Perspective on the NCCN Evidence Blocks provided by Bruce Gould, MD

video-image

Perspective on the ASCO Value Framework provided by Bruce Gould, MD

video-image

Bruce Gould, MD, explains ASCO’s policy toward clinical pathways at this time

video-image

The impact of clinical pathways on quality cancer care as explained by Bruce Gould, MD

video-image

Bruce Gould, MD, describes the concerns his practice has with clinical pathways

video-image

Barbara McAneny, MD, explains why CMS implemented the ASP experiment

video-image

Barbara McAneny, MD, informs as to what practices should know about MACRA

video-image

Barbara McAneny, MD, reviews the COME HOME project’s influence on the Oncology Care Model

video-image

Barbara McAneny, MD, discusses COME HOME’s adaptability to other community oncology practices

video-image

Barbara McAneny, MD, talks about the COME HOME project’s impact on community oncology practices

video-image

Barbara McAneny, MD, discusses the COME HOME project’s future

video-image

Jeff Patton, MD, explains what could happen if the CMS ASP Experiment proceeds as planned by CMS

video-image

Jeff Patton, MD, explains how Tennessee Oncology benefits from being a member of COA

video-image

Jeff Patton, MD, explains why the 2016 COA meeting is a must attend meeting

video-image

Jeff Patton, MD, discusses his new role with the Community Oncology Alliance (COA)

video-image

Deborah Patt, MD, shares her concerns about the CMS ASP Experiment and Part B reimbursement

video-image

Deborah Patt, MD, tells us how chemotherapy costs figure into total care

video-image

Deborah Patt, MD, points out how oncologists can reduce cancer costs

video-image

Deborah Patt, MD, details surprising outcomes from a recent cost study

video-image

Deborah Patt, MD, looks at the bigger expense drivers in cancer care

video-image

David Eagle, MD, gives his opinion on the CMS ASP Experiment

video-image

David Eagle, MD, enumerates what oncologists can do to bring cancer costs down

video-image

David Eagle, MD, lists outcomes from the COA study surprising to oncologists

video-image

David Eagle, MD, details the bigger expenses driving up cancer care costs based on the COA study

video-image

David Eagle, MD, compares costs for treating cancer vs. non-cancer based on the COA study

video-image

David Eagle, MD, talks about COA’s Cost Drivers of Cancer Care study

video-image

Bhuvana Sagar, MD, tells us about the Cigna medical home for oncologists

video-image

Bhuvana Sagar, MD, discusses Cigna’s work with oncologists to find alternative payment models

video-image

Bhuvana Sagar, MD, explains the need for alternative payment models in oncology

video-image

Barry Russo explains the impact of the CMS ASP Experiment

video-image

Practices need to get ready to replace buy and bill explains Barry Russo

video-image

Bruce Gould, MD, explains the characteristics that makes a practice ready for OCM

video-image

Brad Prechtl briefs us on his concerns with the“Medicare Experiment” and its impact

video-image

Brad Prechtl tells how his practice is working to improve cancer care

video-image

Brad Prechtl talks about how community oncology practices can survive today

video-image

Brad Prechtl explains the benefits of community oncology practices joining forces

video-image

Bhuvana Sagar, MD, forecasts the possible Cigna adoption of a Medicare OCM model

video-image

Participation in the Oncology Care Model (OCM) as explained by Barry Russo

video-image

Barry Russo explains how important it is to embrace alternative payment models

video-image

Barry Russo tells us how his practice is getting ready for value-based care

video-image

Patrick Cobb, MD, FACP, looks ahead to treatment innovations that will make a difference

video-image

Patrick Cobb, MD, FACP, talks about some exciting, recent innovations in cancer treatment

video-image

Michael Diaz, MD, talks about working with payers to add quality and value

video-image

Michael Diaz, MD, discusses the challenges in adopting quality and value measures

video-image

Michael Diaz, MD, talks about why the community oncology setting is the best value for patients

video-image

John Fox, MD, predicts if the ASCO Value Framework or NCCN Evidence Blocks will impact drug spend

video-image

John Fox, MD, talks about how Priority might use the ASCO and NCCN value tools

video-image

John Fox, MD, talks about the new value tools from ASCO and NCCN

video-image

John Fox, MD, provides perspective on collaborating with providers on clinical pathways

video-image

A look at cancer clinical pathways with Charles Bane, MD

video-image

Ricky Newton, CPA, updates us on COPA

video-image

Ricky Newton, CPA, details how COPA’s website helps practice managers, pharmacists, and patients

video-image

Ricky Newton, CPA, explains the purpose of COPA’s new In-House and Specialty Pharmacies brief

video-image

Ricky Newton, CPA, tells us what follow up to expect from COPA’s new brief

video-image

Robert Baird fills us in on the Value-Based Purchasing Modifier's impact on Dayton

video-image

Robert Baird details how practices can prepare for the Value-Based Purchasing Modifier and MIPS

video-image

Robert Baird explains how Dayton physicians and payers are collaborating on APMs

video-image

Robert Baird answers questions on Dayton’s participation in the Oncology Care Model

video-image

Skip Burris, MD, outlines the scope of cancer clinical trials at SCRI

video-image

Skip Burris, MD, looks at the promise of immunotherapies in combination

video-image

Skip Burris, MD, explains goals and outcomes of the My Pathway trial

video-image

Skip Burris, MD, reflects on the promise and concerns with liquid biopsies

video-image

Ted Okon tells us why the CNS ASP Experiment is a bad idea

video-image

Embrace alternative payment models explains Ted Okon

video-image

Todd Murphree, PharmD, tells us how in-house dispensing in his practice benefits patients

video-image

Todd Murphree, PharmD, tells us how in-house dispensing in his practice benefits patients

video-image

Todd Murphree, PharmD, explains the role an in-house pharmacy plays in the quality equation

video-image

Sue Naeyaert predicts whether we will see more cancer biosimilars soon

video-image

Sue Naeyaert tells us what to expect in pricing biosimilars

video-image

A look at the expansion of a biosimilar’s FDA label with Sue Naeyaert

video-image

Sue Naeyaert explains the proposed reimbursement of biosimilars by CMS

video-image

Skip Burris, MD, discusses how precision medicine is changing cancer treatment

video-image

Sue Naeyaert provides her vision of the biosimilar products in development

video-image

Todd Murphree briefs us on ACHC’s oncology accreditation process

video-image

Todd Murphree, PharmD, discusses how ACHC accreditation benefits his practice

video-image

Ted Okon discusses the sessions that stand out at this year's annual meeting

video-image

Ted Okon discusses the 2016 Community Oncology Alliance annual meeting

video-image

Ted Okon discusses the 2016 Community Oncology Alliance annual meeting

video-image

Ted Okon provides an overview of the Cost Drivers in Cancer Care study

video-image

Mary Kruczynski speaks to those who were unable to attend the 2016 Annual COA meeting

video-image

Mary Kruczynski tells us how the 2016 Annual COA meeting benefits health care providers

video-image

Mary Kruczynski reflects on highlights from COA

video-image

Lucio Gordan, MD, lists takeaways from COA that can benefit his own practice

video-image

Lucio Gordan, MD, debriefs providers who didn’t attend on highlights from COA

video-image

Lucio Gordan, MD, reflects on key messages from this year’s COA

video-image

Jeff Vacirca, MD, explains the relevance of the COA/Milliman study to his practice

video-image

Jeff Vacirca, MD, talks about what his community oncology practice is doing to survive

video-image

Jeff Patton, MD, explains how his practice is working to develop alternative payment models

video-image

COA is helping community oncologists by fighting the CMS ASP Experiment by Jeff Patton, MD

video-image

Gary Palmer, MD, JD, MBA, describes the clinical utility of the GPS Cancer test

video-image

Gary Palmer, MD, JD, MBA, tells us about the mission of NantWorks and NantHealth

video-image

Gary Palmer, MD, JD, MBA, discusses how precision medicine figures into cancer treatment algorithms

video-image

John Iacuone, MD, MBA, explains what capital improvements and services VCCN provides to oncologists

video-image

John Iacuone, MD, MBA, explains how practices stay independent in pay for performance environment

video-image

John Iacuone, MD, MBA, discusses the economic advantage for oncologists that join the VCCN

video-image

John Iacuone, MD, MBA, explains why Vantage Cancer Care Network was created and their mission

video-image

Kavita Patel, MD, MS discusses how important cancer care management is to Medicare

video-image

Kavita Patel, MD, MS, explains how 340B is impacting cancer care

video-image

Kavite Patel, MD, MS, tells us whether ACOs are having an impact on oncologists

video-image

Kavita Patel, MD, MS, describes the Triple Aim

video-image

Linda Bosserman, MD, discusses the challenges with the rise in consumerism and patient integration

video-image

Linda Bosserman, MD, explains how her practice implemented structural data collection in an EMR

video-image

Linda Bosserman, MD, explains how her private practice served two Safety Net hospitals in her region

video-image

Madelyn Trupkin Herzfeld discuses how cancer patients are involved in treatment decision-making

video-image

Madelyn Trupkin Herzfeld defines patient engagement, and the tools patients use with their care team

video-image

Madelyn Trupkin Herzfeld explains what does Carevive does to help patients with cancer

video-image

Michael Kolodziej, MD, discusses alternative payment models of the future

video-image

Michael Kolodziej, MD, describes the breadth and depth of alternative payment models

video-image

Michael Kolodziej, MD, tells us why alternative payment models are needed

video-image

William Harwin, MD, tells us what smaller practices can learn from his experience

video-image

William Harwin, MD, explains how quality measures are being integrated into his practice

video-image

William Harwin, MD, tells us about the ancillary services his pracdtice has to help patients

video-image

William Harwin, MD, gives his opinion if practices can survive in today's value based environment

video-image

David Lansky gives the employer perspective on quality cancer care

video-image

David Lansky has ideas on how patient reported data can be captured

video-image

David Lansky describes how patient reported outcomes can measure of health care system improvement

video-image

David Lansky explains how can we improve efficiency in the health care system

video-image

Bobby Green, MD, MSCE, discusses Flatiron’s approach to tackling today's value issues

video-image

Bobby Green, MD, MSCE, discusses how we use these data to drive quality

video-image

Bobby Green, MD, MSCE, tells us which data is needed to curate a complete picture of the patient

video-image

Bobby Green, MD, MSCE, explains the frustrations with data coming from oncology practices

video-image

Debra Patt, MD, discusses what the future holds for quality improvement in oncology

video-image

Debra Patt, MD, explains what some of the limitations of quality improvement measurements are

video-image

Debra Patt, MD, tells us the history of quality improvement

video-image

Charles Rosen, MD, discusses avoidable costs in cancer care

video-image

Charles Rosen, MD, explains how team care is important to improving cancer care

video-image

Charles Rosen, MD, discusses the future of specialty care nationally

video-image

Andrew Schorr explains how his story represents a change in the patient and doctor relationship

video-image

Andrew Schorr tells us the information and resources that patients want out of cancer websites

video-image

Andrew Schorr tells us his story as a 2-time cancer survivor

video-image

Robert Baird tells us what MIPS are and how practices might use them

video-image

Patrick Cobb, MD, discusses treatment innovations and managing patient’s expectations

video-image

Jeff Vacirca, MD, shares his thoughts on the “Medicare Experiment” on community oncology

video-image

David Eagle, MD, compares treatment costs in different settings

video-image

Mary Kruczynski tells us how the Cost Drivers in Cancer Care study was developed

video-image

Patrick Soon-Shiong, MD, FRCS(C), FACS, discusses the Cancer Moonshot

video-image

Patrick Soon-Shiong, MD, tells us why it is important to target the tumor microenvironment

video-image

Patrick Soon-Shiong, MD, FRCS(C), FACS, describe the GPS Cancer test

video-image

Patrick Soon-Shiong, MD, FRCS(C), FACS, explains why have we not won the war on cancer

video-image

John Sprandio, MD explains why practices need analytics in an alternative payment model

video-image

John Sprandio, MD discusses why his practice partnered with Vantage Cancer Care Network

video-image

John Sprandio, MD explains why oncologists should practice in an IPA model

video-image

John Sprandio, MD, tells us about the economic reality of an oncology medical home

video-image

John Sprandio, MD, discusses how patient-centered oncology medical homes impacted on ER visits

video-image

John Sprandio, MD, discusses the degree services drive the likelihood of achieving clinical outcomes

video-image

John Sprandio, MD, explains how his practice worked with Capital Blue Cross

video-image

John Sprandio, MD, explains how his practice worked with CMS to help develop the Oncology Care Model

video-image

John Sprandio, MD, discusses the changes his practice made to become a patient centered medical home

video-image

Jennifer Carter, MD, explains how N-of-One uses precision medicine to recommend treatment strategies

video-image

Jennifer Carter, MD, MPH, explains how oncology clinical trial design is adopting precision medicine

video-image

Jennifer Carter, MD, MPH, tells us the biggest challenges facing adoption of precision medicine

video-image

Jennifer Carter, MD, MPH, explains how hospital systems can launch a precision medicine program

video-image

Jennifer Carter, MD, MPH, describes how precision medicine can change the way cancer is treated

video-image

Ira Klein, MD, MBA, FACP, discusses the challenges as we move to a more risk bearing environment

video-image

Ira Klein, MD, MBA, FACP, explains how oncologists can support their primary care colleagues

video-image

Ira Klein, MD, MBA, FACP, discusses if oncology has a meaningful role to play in population health

video-image

Harold Miller explains what types of payment models hold the most promise for oncologists

video-image

Harold Miller discusses PCOP and how it would decrease spending on cancer care

video-image

Harold Miller discusses the opportunities to reduce spending on cancer care without harming patients

video-image

Harold Miller discusses the barriers in the fee for service model

video-image

Gary Palmer, MD, JD, MBA, discusses how NantWorks and NantHealth is involved in the Cancer Moonshot

video-image

Gary Palmer, MD, JD, MBA, tells us when the GPS Cancer test will be available